New Data from Sagimet's Phase 2 FASCINATE-1 Clinical Trial Demonstrate TVB-2640's Positive Effect Across Patients with NASH in the U.S. and China

By In The News
November 12, 2021 in The Headlines

Followers 0

Reply to this topic

Recommended Posts

In The News

Posted November 12, 2021

- Share

Posted November 12, 2021

SAN MATEO, Calif., Nov. 12, 2021 /PRNewswire/ -- Sagimet Biosciences, a clinical-stage biotechnology company, announced today that Rohit Loomba, MD, MHSc, Director, NAFLD Research Center, University of California San Diego, will give an oral presentation on consolidated results from the...

View the full article

Quote

Link to comment

Share on other sites

Reply to this topic...

× Pasted as rich text. Paste as plain text instead

Only 75 emoji are allowed.

× Your link has been automatically embedded. Display as a link instead

× Your previous content has been restored. Clear editor

× You cannot paste images directly. Upload or insert images from URL.

Insert image from URL

Followers 0

Go to topic listing

Most Contributions
1. In The News
  201554
2. Jaydee
  13894
3. Kip Powick
  11834
4. deicer
  10842
5. dagger
  9572
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  251.4k
- Total Posts
  
  523.7k

Sign In

New Data from Sagimet's Phase 2 FASCINATE-1 Clinical Trial Demonstrate TVB-2640's Positive Effect Across Patients with NASH in the U.S. and China

Recommended Posts

In The News

Link to comment

Share on other sites

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support